Patient and deep brain stimulation characteristics and outcomesa

VariableSummary (N = 11)
Patient characteristics
    Age at DBS (mean) (range) (yr)62 (49–73)
    Male sex (No.) (%)10 (90.9%)
    Disease duration (mean) (range) (yr)9 (6–16)
    Handedness (right) (No.) (%)10 (90.9%)
Deep brain stimulation information
    Volume of tissue activated (mm3)
        Caudate
            No. (%) of patients with values of >00 (0.0%)
            Median (minimum, maximum)0.0 (0.0, 0.0)
        GPe
            No. (%) of patients with values of >011 (100.0%)
            Median (minimum, maximum)19.3 (0.8, 78.4)
        M1
            No. (%) of patients with values of >08 (72.7%)
            Median (minimum, maximum)3.6 (0.0, 42.9)
        PPN
            No. (%) of patients with values of >01 (9.1%)
            Median (minimum, maximum)0.0 (0.0, 7.9)
        PFC
            No. (%) of patients with values of >02 (18.2%)
            Median (minimum, maximum)0.0 (0.0, 5.5)
        Putamen
            No. (%) of patients with values of >02 (18.2%)
            Median (minimum, maximum)0.0 (0.0, 38.8)
        SMA/PMC
            No. (%) of patients with values of >06 (54.6%)
            Median (minimum, maximum)4.8 (0.0, 46.5)
        STN
            No. (%) of patients with values of >00 (0.0%)
            Median (minimum, maximum)0.0 (0.0, 0.0)
        SN
            No. (%) of patients with values of >08 (72.7%)
            Median (minimum, maximum)5.8 (0.0, 36.3)
        Thalamus
            No. (%) of patients with values of >01 (9.1%)
            Median (minimum, maximum)0.0 (0.0, 0.5)
Outcomes
    Preoperative UPDRS III score (range)42 (27–55)
    6-Month follow-up UPDRS III score (range)21 (13–40)
    Change in UPDRS III score (preoperative minus 6-month follow-up) (range)15 (−12–31)
  • Note:—PFC indicates prefrontal cortex; PPN, pedunculopontine nucleus.

  • a The sample median (minimum, maximum) is given for continuous variables.